A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites.
Cronstein
B N
BN
New York University Medical Center, NY 10016, USA.
D000241:Adenosine / Q000378:metabolism* / Q000502:physiology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008727:Methotrexate / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine; D000241:Adenosine; D008727:Methotrexate